These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30135928)
21. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro. Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119 [TBL] [Abstract][Full Text] [Related]
22. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Wang JZ; Grundke-Iqbal I; Iqbal K Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267 [TBL] [Abstract][Full Text] [Related]
23. Bushen-Huatan-Yizhi formula reduces spatial learning and memory challenges through inhibition of the GSK-3β/CREB pathway in AD-like model rats. Yang SS; Shi HY; Zeng P; Xia J; Wang P; Lin L Phytomedicine; 2021 Sep; 90():153624. PubMed ID: 34216932 [TBL] [Abstract][Full Text] [Related]
24. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor. Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789 [TBL] [Abstract][Full Text] [Related]
25. Distribution of tau protein kinase I/glycogen synthase kinase-3beta, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain. Takahashi M; Tomizawa K; Ishiguro K Brain Res; 2000 Feb; 857(1-2):193-206. PubMed ID: 10700568 [TBL] [Abstract][Full Text] [Related]
26. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders. Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722 [TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of tau protein over time in rats subjected to transient brain ischemia. Song B; Ao Q; Wang Z; Liu W; Niu Y; Shen Q; Zuo H; Zhang X; Gong Y Neural Regen Res; 2013 Dec; 8(34):3173-82. PubMed ID: 25206638 [TBL] [Abstract][Full Text] [Related]
28. Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3β activation. Zhang Y; Fan X; Su Z; Yuan T; Yin H; Gu H; Zuo Y; Chen S; Zhou H; Su G Environ Toxicol; 2021 Dec; 36(12):2414-2425. PubMed ID: 34432352 [TBL] [Abstract][Full Text] [Related]
29. Regulation of phosphorylation of tau by protein kinases in rat brain. Sengupta A; Grundke-Iqbal I; Iqbal K Neurochem Res; 2006 Dec; 31(12):1473-80. PubMed ID: 17120162 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons. Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330 [TBL] [Abstract][Full Text] [Related]
31. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner. Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916 [TBL] [Abstract][Full Text] [Related]
32. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease. Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096 [TBL] [Abstract][Full Text] [Related]
33. TPPU protects tau from H Yao ES; Tang Y; Liu XH; Wang MH J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507 [TBL] [Abstract][Full Text] [Related]
34. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro. Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328 [TBL] [Abstract][Full Text] [Related]
35. GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats. Wei Z; Mahaman YAR; Zhu F; Wu M; Xia Y; Zeng K; Yang Y; Liu R; Wang JZ; Shu X; Wang X Aging (Albany NY); 2019 Sep; 11(18):7978-7995. PubMed ID: 31548435 [TBL] [Abstract][Full Text] [Related]
36. Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein Phosphorylation. Yu UY; Yoo BC; Ahn JH Korean J Physiol Pharmacol; 2014 Apr; 18(2):155-61. PubMed ID: 24757378 [TBL] [Abstract][Full Text] [Related]
37. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation. Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846 [TBL] [Abstract][Full Text] [Related]
39. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells. Wu X; Kosaraju J; Tam KY Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686 [TBL] [Abstract][Full Text] [Related]
40. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. Michel G; Mercken M; Murayama M; Noguchi K; Ishiguro K; Imahori K; Takashima A Biochim Biophys Acta; 1998 Apr; 1380(2):177-82. PubMed ID: 9565682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]